As of Mar 05
| +0.05 / +1.01%|
The 1 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +79.28% increase from the last price of 5.02.
The current consensus among 1 polled investment analysts is to Buy stock in Sinovac Biotech Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.